节点文献

2000―2021年南京市HIV/AIDS患者生存状况及影响因素的回顾性队列

Analysis on the survival status and influencing factors of HIV/AIDS: a retrospective cohort study from 2000 to 2021 in Nanjing, China

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 徐园园李小杉王静文仇蓓蓓吴苏姝李昕时红杰朱正平

【Author】 XU Yuanyuan;LI Xiaoshan;WANG Jingwen;QIU Beibei;WU Sushu;LI Xin;SHI Hongjie;ZHU Zhengping;Department of AIDS/STD Control and Prevention, Nanjing Municipal Center for Disease Control and Prevention;Department of Lung Transplant Center, Nanjing Medical University Affiliated Wuxi People′s Hospital;Department of Chronic Infectious Disease Control and Prevention, Nanjing Municipal Center for Disease Control and Prevention;

【通讯作者】 朱正平;

【机构】 南京市疾病预防控制中心艾滋病性病防制科南京医科大学附属无锡市人民医院肺移植中心南京市疾病预防控制中心慢性传染病防制科

【摘要】 目的 了解南京市人类免疫缺陷病毒(human immunodeficiency virus, HIV)感染者/艾滋病(acquired immune deficiency syndrome, AIDS)患者(简称HIV/AIDS患者)的生存状况及其影响因素。方法 利用2000―2021年艾滋病综合防治信息系统中HIV/AIDS患者相关数据,采用回顾性队列研究方法,采用Kaplan-Meier法拟合生存曲线、Cox比例风险回归模型分析AIDS相关死亡的影响因素。结果 5 903例HIV/AIDS患者中,AIDS相关死亡率为0.93/100人年,第1、5、10和22年的累积生存率分别为97.2%、95.3%、92.9%和90.0%。多因素Cox比例风险回归模型显示,与未治疗的HIV/AIDS患者相比,诊断后越早开始抗病毒治疗(antiretroviral therapy, ART)的患者,其AIDS相关死亡风险越低。基线病毒载量(viral load, VL)≥80 000 copies/mL者的死亡风险是<20 000 copies/mL者的6.54倍。与ART治疗前首次CD4~+T淋巴细胞(简称CD4)计数<200个/μL相比,CD4计数越高的AIDS相关死亡风险越低。ART对延长首次CD4计数<200个/μL的HIV/AIDS生存时间具有更好的效果。结论 南京市HIV/AIDS患者中AIDS相关死亡率较低,其中早期确诊、较低的基线VL、快速启动ART是AIDS相关死亡的保护因素。因此,在促进HIV早发现的基础上,应加强VL基线监测、优化随访管理流程、快速启动ART,从而进一步降低HIV/AIDS患者相关死亡风险。

【Abstract】 Objective To investigate the survival status and influencing factors of human immunodeficiency virus(HIV)/acquired immune deficiency syndrome(AIDS)(HIV/AIDS) patients in Nanjing. Methods The retrospective cohort study of newly diagnosed HIV was conducted in Nanjing and used citywide data from the HIV/AIDS Comprehensive Information Management System from 2000 to 2021. Kaplan-Meier and cox proportional hazard regression method were used to draw the survival curve and analyze the factors associated with AIDS-related deaths, respectively. Results Among 5 903 HIV/AIDS cases, the AIDS-related mortality was 0.93 per 100 person-years and the cumulative survival rates at 1, 5, 10, and 22 years were 97.2%, 95.3%, 92.9%, and 90.0%, respectively. Multivariate analysis revealed that compared to untreated HIV/AIDS, the earlier the initiation of antiretroviral therapy(ART) after diagnosis, the lower the AIDS-related death risk. The HIV/AIDS with a baseline viral load(VL) ≥80 000 copies/mL had 6.54 times higher AIDS-related death risk than those with VL <20 000 copies/mL. Compared to the first CD4 count before ART <200 cells/μL, the higher the CD4 level, the lower the AIDS related death risk. ART was more effective in prolonging survival time among those with first CD4 count before ART <200 cells/μL. Conclusions The AIDS-related mortality of HIV/AIDS is low in Nanjing. Early diagnosis, low baseline VL and rapid initiation of ART are protective factors for AIDS-related death. Therefore, on the basis of promoting the early diagnosis of HIV, we should strengthen the baseline monitoring of VL, optimize the follow-up management process to promote rapid ART, so as to further reduce the risk of AIDS-related death.

【基金】 国家自然科学基金(82103896);江苏省社科应用研究精品工程课题(23SYC-007);南京市卫生科技发展专项资金项目(ZKX23059,YKK23192);南京医科大学南京公共卫生研究院创新强基项目(NQJ2301);南京市疾控中心青年人才科研培育团队项目(NPY2307)~~
  • 【文献出处】 中华疾病控制杂志 ,Chinese Journal of Disease Control and Prevention , 编辑部邮箱 ,2024年12期
  • 【分类号】R512.91
  • 【下载频次】16
节点文献中: 

本文链接的文献网络图示:

本文的引文网络